VANCOUVER, May 19 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its Quill(TM) SRS wound closure product line is now available for purchase online in the U.S. on its website at https://ecommerce.angiotech.com/Main/Home.aspx. The Quill SRS products are the first Angiotech products available online and include the Polydioxanone (PDO), MONODERM(TM), Nylon and Polypropylene product lines.
"We strive to be innovative, not just in the development of our products, but in all aspects of our business," said Dr. William Hunter, President and CEO of Angiotech. "We are very pleased with the development of our e-commerce site and believe the ability to order Quill SRS products online will be much easier and more convenient for our customers than the existing ordering methods. We hope to add other Angiotech products to the site in the future to better serve our customers."
About the Quill(TM) Self-Retaining System (SRS)
The Quill SRS product line represents a revolutionary technology in wound closure made possible by bidirectional fixation within the wound. Its patented design allows the surgeon to begin closure at the midpoint of the wound and suture in two directions from the midpoint. Barbs within the Quill SRS product distribute tension across the wound and eliminate the need for knots.
Forward Looking Statements --------------------------
Statements contained in this press release that are not based on historical fact, including without limitation statements containing the words "believes," "may," "plans," "will," "estimates," "continues," "anticipates," "intends," "expects" and similar expressions, constitute "forward-looking statements" within the meaning of th
|SOURCE Angiotech Pharmaceuticals, Inc.|
Copyright©2009 PR Newswire.
All rights reserved